An observational study in Critical Limb Ischemia (CLI), Popliteal Nerve Block and ESPB, sponsored by Minia University Hospital. Completed at 1 site in Egypt. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-04-06.
Sponsored by Minia University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Chronic Limb-Threatening Ischemia with a site in Egypt — 2 open to participants now, 5 under way, none of them phase 3. Chronic Limb-Threatening Ischemia · Egypt.
Among the 10 studies in Chronic Limb-Threatening Ischemia with a site in Egypt, this one is one of 2 that started in 2024, is one of 6 observational ones, and was the 6th registered.
359 studies on the registry are indexed under Chronic Limb-Threatening Ischemia; 73 are open to participants now.
Browse Chronic Limb-Threatening Ischemia studies →2 of the 10 studies in Chronic Limb-Threatening Ischemia with a site in Egypt are open now. Recruiting first, the newest first:
Sohag University · Sites in Egypt
Ages 40+
Assiut University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 51 Chronic Limb-Threatening Ischemia studies recruiting now, 35 (69%) set no upper age limit and 2 (4%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 20 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 2 started in 2024.
This study's enrollment of 70 is below the median of 111 across 104 observational studies indexed under Chronic Limb-Threatening Ischemia.
Median enrollment 45 across the 4 interventional studies, 65 across the 6 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 6 most frequent:
Minia University Hospital is the lead sponsor of 7 studies on the registry; 5 are open to participants now.
Minia University Hospital has 1 study filed under Chronic Limb-Threatening Ischemia — fewer than ten, so there is no comparison to draw.
1 of the studies in Chronic Limb-Threatening Ischemia with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07488637Assiut UniversityWoundsome Revascularization in Chronic Limb-Threatening Ischemia | 2027-10-01 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Chronic Limb-Threatening Ischemia with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Comparison of popliteal sciatic nerve block and erector spinae plane block (ESPB) in patients undergoing endovascular management of critical lower limb ischemia (CLI).
Nerve blocks, particularly regional anesthesia techniques, have been increasingly used in the endovascular management of critical lower limb ischemia (CLI). These techniques offer numerous advantages over general and local anesthesia.
Primary Advantages of Nerve Blocks:
Superior Pain Control
Nerve blocks, such as femoral and sciatic nerve blocks, provide effective pain relief by anesthetizing the nerve supply to the lower limb.
They offer more comprehensive analgesia than local anesthesia alone, as they numb the entire area around the puncture site.
Enhanced Patient Comfort
Nerve blocks allow patients to remain pain-free during and after the procedure.
They minimize discomfort even in lengthy or complex cases.
Reduction in Systemic Analgesic Requirements
By providing localized anesthesia, nerve blocks significantly reduce the need for systemic analgesics, particularly opioids.
This is essential because CLI patients often have comorbidities that make opioid use risky.
Fewer Opioid-Related Side Effects
Nerve blocks reduce the incidence of opioid-related side effects, including nausea, vomiting, respiratory depression, and sedation.
Nerve blocks preserve autonomic nervous system function, reducing fluctuations in blood pressure and heart rate compared to general anesthesia.
This is especially beneficial for CLI patients, who frequently have underlying cardiovascular disease.
Both sexes and from 20 to 80 years
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in this group will receive an ultrasound-guided sciatic popliteal nerve block for anesthesia during endovascular management of critical lower limb ischemia.
Procedure: Popliteal sciatic nerve block
Patients in this group will receive an ultrasound-guided erector spinae plane block for anesthesia during endovascular management of critical lower limb ischemia.
Procedure: Popliteal sciatic nerve block
Procedure/Surgery: Patients will receive either an ultrasound-guided sciatic popliteal nerve block or an ultrasound-guided erector spinae plane block for anesthesia during endovascular management of critical lower limb ischemia.
Block quality
Assessment of the occurrence of complete motor and sensory block.
Time frame: Baseline (immediately after block administration).
Postoperative Analgesia Duration
Time from block administration to the first request for rescue analgesia. .
Time frame: Up to 24 hours postoperatively.
Ran from Mar 2024 to primary completion in Oct 2024, 7 months.
Of 47 non-industry observational studies under Chronic Limb-Threatening Ischemia, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 60. This study's 7 months is below that.
Counting every sponsor, half of 53 studies reached it within 34 months; a quarter within 22 and three quarters within 59.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chronic Limb-Threatening Ischemia →
Minia University Hospital